Cargando…
Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?
Sodium-glucose co-transporter 2 inhibitors (iSGLT2) have been linked to cardiovascular risk reduction in patients with type 2 diabetes (T2D). However, their underlying molecular mechanisms remain unclear. This study aimed to evaluate the effects of empagliflozin, a novel potent and selective iSGLT-2...
Autores principales: | Canet, Francisco, Iannantuoni, Francesca, de Marañon, Aránzazu Martínez, Díaz-Pozo, Pedro, López-Domènech, Sandra, Vezza, Teresa, Navarro, Blanca, Solá, Eva, Falcón, Rosa, Bañuls, Celia, Morillas, Carlos, Rocha, Milagros, Víctor, Víctor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389001/ https://www.ncbi.nlm.nih.gov/pubmed/34439476 http://dx.doi.org/10.3390/antiox10081228 |
Ejemplares similares
-
Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glycemic Control
por: de Marañón, Aranzazu Martinez, et al.
Publicado: (2020) -
Mitochondrial Alterations and Enhanced Human Leukocyte/Endothelial Cell Interactions in Type 1 Diabetes
por: Iannantuoni, Francesca, et al.
Publicado: (2020) -
The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
por: Iannantuoni, Francesca, et al.
Publicado: (2019) -
Relationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes
por: De Marañon, Aranzazu M., et al.
Publicado: (2020) -
The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
por: Escribano-Lopez, Irene, et al.
Publicado: (2018)